Cancer Therapy Flashcards

1
Q

What are the two types of radiotherapy?

A
  • radical type: for curing

- palliative type: for symptom relief

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Adjuvant Chemotherapy

A
  • used after successful surgical resection (post-op)

- kills any micrometastases to prevent recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Neoadjuvant Chemotherapy

A
  • used before surgery (pre-op)

- decreases tumor size; makes the surgery easier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Are there any cells that are relatively insensitive to chemo?

A
  • yes, quiescent cells in G0 and hypoxic cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does chemotherapy target?

A
  • the DNA of rapidly-dividing / highly-active cells (cancer cells)
  • normal cells are also affected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Antitumor Antibiotics

A
  • natural products isolated from fungi in the soil (such as Streptomyces sp.)
  • form complexes with DNA, preventing replication
  • non cell cycle specific
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antimetabolites (2 subgroups)

A
  • interfere with the incorporation of nucleotides into DNA
  • cell cycle specific (S phase)
  • 1) nucleotide analogs (can resemble purines or pyrimidines)
  • 2) antifolates: inhibit folic acid, which is needed for biosynthesis of amino acids and nucleotides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Alkylating Agents

A
  • form unstable alkyl groups that react with e- rich sites (nucleic acids, DNA); basically, they attach alkyl groups to DNA
  • non cell cycle specific
  • tend to target rapidly proliferating tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Platinum Analogs

A
  • grouped in with alkylating agents because of similar mechanism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antimicrotubular Agents (4 subgroups)

A
  • disrupt microtubules, arresting mitotic cell division
  • cell cycle specific (M phase)
  • 1) taxanes, 2) vinca alkaloids, 3) halichondran B analog, 4) epothilanes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Topoisomerase Inhibitors

A
  • stabilize topoisomerase-DNA complexes, preventing repair of the DNA breaks the complex made
  • cell cycle specific (S phase)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does Topoisomerase function?

A
  • forms a temporary complex with DNA and then breaks the DNA at certain points to prevent tangling during replication; these breaks are quickly repaired once the protein leaves
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Irinotecan

A
  • a topoisomerase I inhibitor
  • a pro-drug that needs to be activated in the liver by carboxylesterase
  • activated form = SN-38
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which normal tissues are most affected by chemotherapy?

A
  • cells of the GIT and bone marrow, because they are actively dividing and metabolic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Myelosuppression

A
  • bone-marrow suppression
  • a major toxicity issue of chemotherapy
  • chemo results in immunosuppression due to neutropenia and leukopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Endocrine Therapy?

A
  • exogenous administration of hormones to control cancer

- is the mainstay therapy for breast and prostate cancers

17
Q

TKIs

A
  • (small molecule) Tyrosine Kinase Inhibitors
  • bind to epidermal growth factor receptors (EGFRs) of cancer cells and prevent the initiation of the signal cascade that would normally trigger proliferation
18
Q

Cetuximab & Panitumumab

A
  • monoclonal antibodies that competitively inhibit EGFR binding to its ligand, preventing the signaling for growth
19
Q

What is the idea behind cancer immunotherapy?

A
  • to tip the balance from tolerance for cancer cells to activation against them
20
Q

CTLA-4

A
  • Cytotoxic T Lymphocyte Antigen-4
  • induces tolerance of the cell expressing it
  • cancer cells produce an over abundance of CTLA-4
21
Q

PD-1

A
  • Programmed Death-1

- inhibits T-cell activation against cells expressing it

22
Q

Nivolumab

A
  • inhibits PD-1, allowing an immune response to attack the target cells
23
Q

Ipilimumab

A
  • blocks CTLA-4, removing immune tolerance for the target cells and allowing attack